UNSPSC 51111738: Datelliptium

This classification denotes an intercalating agent with the molecular formula C23H28N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L374Y6WE0D, chemically known as 2-(2-(diethylamino)ethyl)-9-hydroxy-5,11-dimethyl-6h-pyrido(4,3-b)carbazolium but generally known as datelliptium, which bears US NIH Compound Identifier 72035. European Medicines Agency schedules Datelliptium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06916MIG.

UNSPSC 51111738 Datelliptium, a Commodity code, does not align with the state and local procurement activity tagged under it in recent solicitations. The code's nominal scope bears no clear relationship to the work actually being solicited — Seminole County, Florida is seeking naloxone and drug deactivation systems; the Texas Health and Human Services Commission is gathering market intelligence on direct-to-manufacturer pharmaceutical programs; the City of Tampa is procuring medical and first aid supplies for fire rescue operations; and the Minnesota Multistate Cooperative Purchasing Alliance is establishing contracts for generic pharmaceuticals and over-the-counter products. None of these solicitations involve datelliptium or a comparable chemical or pharmaceutical product that would justify assignment to this code. The mismatch suggests either a cataloging error in the procurement management system or a misapplication of the UNSPSC taxonomy to these health-supply and pharmaceutical opportunities.

The code shows little relevant recent activity. Vendors evaluating pursuit under UNSPSC 51111738 should verify the actual commodity or service scope they intend to target and confirm proper code assignment before developing a market strategy, as the current tagging under this code does not reflect consistent or meaningful procurement intent.